anti-AAV9 antibody product blog
Tags: Antibody; Monoclonal Antibody; AAV9; anti-AAV9 antibody;
The AAV9 n/a (Catalog #MBS533228) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The AAV9 antibody reacts with specifically reacts with intact adeno-associated virus particles, empty and full capsids. Recognizes a conformational epitope of assembled capsids. Cannot be used for immunoblotting. Specific for Human AAV-9 and may cross-react with other species as described in the data sheet. MyBioSource\'s AAV9 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF) microscopy, Immunohistochemistry (IHC), Dot Blot-non-denaturing conditions (DB). Researchers should empirically determine the suitability of the AAV9 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal AAV9 antibody.
Biological Significance: Adeno-associated virus (AAV) is a small virus which infects humans and some other primate species. AAV is not currently known to cause disease and consequently the virus causes a very mild immune response. AAV can infect both dividing and non-dividing cells and may incorporate its genome into that of the host cell. Immunogen: Recombinant produced adeno-associated virus type 9 (AAV-9) vector carrying GFP. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing AAV9 are readily searchable from our website. Different antibodies against the same target such as AAV9 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.